Chiral FA Conjugated CdTe/CdS Quantum Dots for Selective Cancer Ablation

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Materials Science

Background:

• Apoptosis induction is a key strategy for cancer therapy.
• Targeted drug delivery systems are crucial for effective cancer treatment.
• Quantum dots (QDs) offer unique optical properties for biomedical applications.

Purpose of the Study:

• To fabricate chiral folic acid (FA)-conjugated Cys-CdTe/CdS quantum dots (QDs) for targeted cancer apoptosis induction.
• To investigate the ligand-induced chirality mechanism of FA-Cys-CdTe/CdS QDs.
• To evaluate the in vivo efficacy and toxicity of these chiral QDs for cancer ablation.

Main Methods:

• Fabrication of chiral FA-conjugated Cys-CdTe/CdS QDs.
• Density functional theory (DFT) simulation to verify chirality mechanism.
• Circular dichroism (CD) spectroscopy for cell differentiation.
• In vitro and in vivo experiments to assess apoptosis induction and cancer ablation.

Main Results:

• Chiral FA-Cys-CdTe/CdS QDs effectively distinguished breast cancer cells from normal cells via CD signals.
• The QDs demonstrated significant apoptosis induction by releasing mitochondrial apoptotic factors.
• In vivo studies confirmed efficient cancer ablation with negligible toxicity.

Conclusions:

• Chiral FA-Cys-CdTe/CdS QDs are effective in targeted cancer cell identification and apoptosis induction.
• These QDs show significant potential as a targeted anticancer agent for clinical applications.
• The developed QDs offer a promising approach for cancer therapy with improved safety profile.